Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. [electronic resource]
- Cancer Dec 1997
- 2583-90 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/(sici)1097-0142(19971215)80:12+<2583::aid-cncr34>3.3.co;2-8 doi
Animals Antineoplastic Agents, Phytogenic--therapeutic use Bone Marrow--drug effects Combined Modality Therapy Female Humans Mammary Neoplasms, Experimental--therapy Mice Mice, Inbred BALB C Mice, Nude Paclitaxel--therapeutic use Radioimmunotherapy Tumor Cells, Cultured Weight Loss Yttrium Radioisotopes--therapeutic use